Targeted multimodal liposomes for imaging and radionuclide therapy

42 (2003) 439]. We aim to translate and utilize achievements from that field of drug delivery research towards successful application of similar carriers for both imaging and radionuclide therapy. In that respect we focus on targeted multimodal carriers that combine an imaging (MRI and/or SPECT) and a therapeutic component. The latter can be a radionuclide or a compound that after neutron capture is able to produce radiation. In principle combinations with a chemotherapeutic modality are feasible as well. To achieve this collaboration of various expert groups in imaging and nuclear medicine is required. This contribution gives an update of the progress in the different areas.